Two human monoclonal SARS-CoV-2 antibodies that maintain neutralizing potency against the SARS-CoV-2 Omicron BA.1 and BA.2 variants

Qianqian Zheng; Liangwei Duan; Zhihua Jiang; Tingxuan Gu; Bojie Zhang; Jiaoyang Li; Yang Zhang; Shiyu Zhang; Yinming Liang; Hui Wang

doi:10.1016/j.gendis.2022.05.027

您当前的位置：

首页 >

文章列表页 >

Two human monoclonal SARS-CoV-2 antibodies that maintain neutralizing potency against the SARS-CoV-2 Omicron BA.1 and BA.2 variants

Short communication | 更新时间：2023-08-29

- Two human monoclonal SARS-CoV-2 antibodies that maintain neutralizing potency against the SARS-CoV-2 Omicron BA.1 and BA.2 variants
- Two human monoclonal SARS-CoV-2 antibodies that maintain neutralizing potency against the SARS-CoV-2 Omicron BA.1 and BA.2 variants
- Genes & Diseases 2023年10卷第3期
- 作者机构：
  
  1. KMD Bioscience (Tianjin) Company Limited,Tianjin,China,301723
  2. Henan Key Laboratory of Immunology and Targeted Drugs, School of Laboratory Medicine, Xinxiang Medical University,Henan,Xinxiang,China,453003
  3. Department of Pathophysiology, School of Basic Medical Sciences, Academy of Medical Science, College of Medicine, Zhengzhou University,Henan,Zhengzhou,China,450001
  4. US (Henan) Hormel Cancer Institute,,, China,Henan,Zhengzhou,China,450008
  5. Henan Collaborative Innovation Center of Molecular Diagnosis and Laboratory Medicine, Xinxiang Medical University,Henan,Xinxiang,China,453003
- 作者简介：
- 基金信息：
- DOI：10.1016/j.gendis.2022.05.027
  中图分类号：
- 纸质出版日期：2023，
  
  网络出版日期：2023-5-1，
扫描看全文
Qianqian Zheng, Liangwei Duan, Zhihua Jiang, 等. Two human monoclonal SARS-CoV-2 antibodies that maintain neutralizing potency against the SARS-CoV-2 Omicron BA.1 and BA.2 variants[J]. Genes & Diseases, 2023,10(3).

Qianqian Zheng, Liangwei Duan, Zhihua Jiang, et al. Two human monoclonal SARS-CoV-2 antibodies that maintain neutralizing potency against the SARS-CoV-2 Omicron BA.1 and BA.2 variants[J]. Genes & Diseases, 2023,10(3).
Qianqian Zheng, Liangwei Duan, Zhihua Jiang, 等. Two human monoclonal SARS-CoV-2 antibodies that maintain neutralizing potency against the SARS-CoV-2 Omicron BA.1 and BA.2 variants[J]. Genes & Diseases, 2023,10(3). DOI： 10.1016/j.gendis.2022.05.027.

Qianqian Zheng, Liangwei Duan, Zhihua Jiang, et al. Two human monoclonal SARS-CoV-2 antibodies that maintain neutralizing potency against the SARS-CoV-2 Omicron BA.1 and BA.2 variants[J]. Genes & Diseases, 2023,10(3). DOI： 10.1016/j.gendis.2022.05.027.

摘要

Abstract

关键词

Keywords

references

查看原文

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

暂无数据

Two human monoclonal SARS-CoV-2 antibodies that maintain neutralizing potency against the SARS-CoV-2 Omicron BA.1 and BA.2 variants

Two human monoclonal SARS-CoV-2 antibodies that maintain neutralizing potency against the SARS-CoV-2 Omicron BA.1 and BA.2 variants

DOI：10.1016/j.gendis.2022.05.027

摘要

Abstract

关键词

Keywords

references